middle.news

INOVIQ’s CAR-NK-Exosomes Eradicate 90% of Aggressive Breast Cancer Cells In Vitro

12:32pm on Monday 22nd of September, 2025 AEST Healthcare
Read Story

INOVIQ’s CAR-NK-Exosomes Eradicate 90% of Aggressive Breast Cancer Cells In Vitro

12:32pm on Monday 22nd of September, 2025 AEST
Key Points
  • CAR-NK-exosomes achieve rapid, potent tumor cell killing in vitro
  • Over 90% of triple-negative breast cancer cells eliminated within 10 hours
  • Independent validation conducted at Peter MacCallum Cancer Centre
  • Next phase – in vivo efficacy studies in TNBC mouse models planned for Q4 2025
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Inoviq (ASX:IIQ)
OPEN ARTICLE